Biogen, Inc. (BIIB)
250.69
-3.15
(-1.24%)
USD |
NASDAQ |
Oct 23, 16:00
247.18
-3.51
(-1.40%)
After-Hours: 20:00
Biogen Price : 250.69 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 251.68 | 252.44 | 246.15 | 250.69 | 1.157M |
| Oct 22, 2026 | 240.61 | 254.41 | 240.02 | 253.84 | 2.238M |
| Oct 21, 2026 | 242.02 | 243.32 | 240.13 | 240.98 | 812899.0 |
| Oct 20, 2026 | 236.79 | 244.65 | 235.96 | 243.10 | 1.492M |
| Oct 19, 2026 | 231.81 | 236.00 | 231.04 | 233.48 | 949716.0 |
| Oct 16, 2026 | 235.75 | 236.87 | 232.36 | 232.65 | 1.463M |
| Oct 15, 2026 | 236.46 | 240.99 | 235.22 | 235.35 | 1.572M |
| Oct 14, 2026 | 228.99 | 234.20 | 228.00 | 232.83 | 1.947M |
| Oct 13, 2026 | 230.34 | 231.04 | 226.71 | 228.90 | 1.049M |
| Oct 12, 2026 | 233.98 | 238.24 | 229.00 | 229.41 | 1.462M |
| Oct 09, 2026 | 220.62 | 227.20 | 219.22 | 225.71 | 815007.0 |
| Oct 08, 2026 | 220.15 | 223.08 | 215.73 | 218.43 | 1.339M |
| Oct 07, 2026 | 222.93 | 228.00 | 221.40 | 222.15 | 1.298M |
| Oct 06, 2026 | 224.53 | 225.97 | 218.00 | 222.89 | 1.008M |
| Oct 05, 2026 | 219.90 | 223.85 | 218.22 | 223.59 | 951320.0 |
| Oct 02, 2026 | 222.98 | 224.08 | 219.81 | 219.88 | 780428.0 |
| Oct 01, 2026 | 225.50 | 228.31 | 222.50 | 222.82 | 1.755M |
| Sep 30, 2026 | 227.23 | 229.36 | 225.50 | 225.88 | 1.553M |
| Sep 29, 2026 | 227.02 | 229.41 | 224.45 | 227.07 | 1.161M |
| Sep 28, 2026 | 225.87 | 230.49 | 225.51 | 228.69 | 1.332M |
| Sep 25, 2026 | 228.27 | 228.92 | 223.76 | 227.60 | 958031.0 |
| Sep 24, 2026 | 226.80 | 228.72 | 224.30 | 226.36 | 1.035M |
| Sep 23, 2026 | 226.94 | 229.19 | 222.36 | 227.53 | 1.494M |
| Sep 22, 2026 | 219.22 | 226.43 | 219.00 | 225.36 | 1.112M |
| Sep 21, 2026 | 216.14 | 221.92 | 214.59 | 219.07 | 928562.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 285.64 |
| Gilead Sciences, Inc. | 156.04 |
| Amgen, Inc. | 439.26 |
| Ionis Pharmaceuticals, Inc. | 42.93 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
Price Related Metrics
| PE Ratio | 44.40 |
| PS Ratio | 3.833 |
| Price to Book Value | 1.964 |
| Price to Free Cash Flow | 14.87 |
| Earnings Yield | 2.25% |
| Market Cap | 37.03B |
| Operating PE Ratio | 19.66 |
| Normalized PE Ratio | 27.44 |